Label Changes for:
Aldactone (spironolactone) Tablets
Changes have been made to the CONTRAINDICATIONS, WARNINGS, PRECAUTIONS and ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June 2013
- Addison’s disease or other conditions associated with hyperkalemia, and with concomitant use of eplerenone.